A community-partnered approach for diversity in COVID-19 vaccine clinical trials.

ABSTRACT:

Introduction

Communities of color have faced disproportionate morbidity and mortality from COVID-19, coupled with historical underrepresentation in US clinical trials, creating challenges for equitable participation in developing and testing a safe and effective COVID-19 vaccine.

Methods

To increase diversity, including racial and ethnic representation, in local Los Angeles County NIH-sponsored Phase 3 SARS-CoV-2 vaccine clinical trials, we used deliberative community engagement approaches to form a Community Consultant Panel (CCP) that partnered with trial research teams. Thirteen members were recruited, including expertise from essential workers, community-based and faith-based organizations, or leaders from racial and ethnic minority communities.

Results

Working cl

SUBMITTER: Castellon-Lopez Y 

PROVIDER: S-EPMC9874035 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature